Evidence map›Paper›PMID 35184697›Full record

ArticleBioengineered2022

Long non-coding RNA RGMB-AS1 represses nasopharyngeal carcinoma progression via binding to forkhead box A1.

Tian Zhang, Ying Jin, Xiangmei Luo

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Bioengineered, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Tian ZhangDepartment of ENT and HN Surgery, Affiliated Hospital of Guizhou Medical University, Guiyang, PR China.
Ying JinDepartment of ENT and HN Surgery, Affiliated Hospital of Guizhou Medical University, Guiyang, PR China.
Xiangmei LuoDepartment of ENT and HN Surgery, Central People's Hospital of ZhanJiang, ZhanJiang, PR China.
Affiliated Hospital of Guizhou Medical University · CNCentral People's Hospital of Zhanjiang · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Long non-coding RNA RGMB-AS1 (RGMB antisense RNA 1) plays a crucial role in tumor progression. However, its underlying mechanism in nasopharyngeal carcinoma (NPC) remains unclear. In this study, we analyzed the clinical significance of lncRNA RGMB-AS1 as a possible potential marker in NPC, and investigated the effect and mechanism of lncRNA RGMB-AS1 on proliferation, migration and epithelial mesenchymal transformation (EMT) of NPC by directly binding Forkhead box A1 (FOXA1) in

Indexed as

Hepatocyte Nuclear Factor 3-alphaNasopharyngeal CarcinomaNasopharyngeal NeoplasmsRNA, Long NoncodingCell Line, TumorCell MovementCell ProliferationGene Expression Regulation, NeoplasticHumansFOXA1 protein, humanHepatocyte Nuclear Factor 3-alphalong noncoding RNA RGMB-AS1, humanRNA, Long NoncodingEMTFOXA1lncRNA RGMB-AS1Nasopharyngeal carcinomaproliferation

Identifiers

PMID35184697
PMCPMC8973592
OpenAlexW4213300534

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.